124 related articles for article (PubMed ID: 38064693)
41. Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas.
Ogiwara T; Nagm A; Nakamura T; Mbadugha T; Horiuchi T; Hongo K
World Neurosurg; 2019 Aug; 128():e752-e759. PubMed ID: 31077893
[TBL] [Abstract][Full Text] [Related]
42. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Buchfelder M
J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
[TBL] [Abstract][Full Text] [Related]
43. Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures.
Halvorsen H; Ramm-Pettersen J; Josefsen R; Rønning P; Reinlie S; Meling T; Berg-Johnsen J; Bollerslev J; Helseth E
Acta Neurochir (Wien); 2014 Mar; 156(3):441-9. PubMed ID: 24343227
[TBL] [Abstract][Full Text] [Related]
44. Pseudocapsular resection in elderly patients with non-functioning pituitary adenoma.
Kinoshita Y; Taguchi A; Tominaga A; Arita K; Yamasaki F
Clin Neurol Neurosurg; 2021 Nov; 210():106997. PubMed ID: 34741976
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma.
Gopalan R; Schlesinger D; Vance ML; Laws E; Sheehan J
Neurosurgery; 2011 Aug; 69(2):284-93. PubMed ID: 21792138
[TBL] [Abstract][Full Text] [Related]
46. Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma.
Bodhinayake I; Ottenhausen M; Mooney MA; Kesavabhotla K; Christos P; Schwarz JT; Boockvar JA
Clin Neurol Neurosurg; 2014 Apr; 119():75-9. PubMed ID: 24635930
[TBL] [Abstract][Full Text] [Related]
47. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
Lampropoulos KI; Samonis G; Nomikos P
Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
[TBL] [Abstract][Full Text] [Related]
48. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.
Iwata H; Sato K; Tatewaki K; Yokota N; Inoue M; Baba Y; Shibamoto Y
Neuro Oncol; 2011 Aug; 13(8):916-22. PubMed ID: 21665918
[TBL] [Abstract][Full Text] [Related]
49. Radiologic Predictors for Extent of Resection in Pituitary Adenoma Surgery. A Single-Center Study.
Sanmillán JL; Torres-Diaz A; Sanchez-Fernández JJ; Lau R; Ciller C; Puyalto P; Gabarrós A
World Neurosurg; 2017 Dec; 108():436-446. PubMed ID: 28899832
[TBL] [Abstract][Full Text] [Related]
50. Clinical and Radiographic Characteristics Related to Hyperprolactinemia in Nonfunctioning Pituitary Adenomas.
Park SS; Kim JH; Kim YH; Lee JH; Dho YS; Shin CS
World Neurosurg; 2018 Nov; 119():e1035-e1040. PubMed ID: 30144593
[TBL] [Abstract][Full Text] [Related]
51. Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas.
Hlaváč M; Knoll A; Etzrodt-Walter G; Sommer F; Scheithauer M; Coburger J; Wirtz CR; Pala A
Neurosurg Rev; 2019 Sep; 42(3):737-743. PubMed ID: 30949920
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis.
Chen Y; Cai F; Cao J; Gao F; Lv Y; Tang Y; Zhang A; Yan W; Wang Y; Hu X; Chen S; Dong X; Zhang J; Wu Q
Front Endocrinol (Lausanne); 2021; 12():793337. PubMed ID: 34970226
[TBL] [Abstract][Full Text] [Related]
53. Suprasellar pituitary adenomas: a 10-year experience in a single tertiary medical center and a literature review.
Zhu J; Wang Z; Zhang Y; Liu J; Li X; Deng K; Lu L; Yao Y
Pituitary; 2020 Aug; 23(4):367-380. PubMed ID: 32378170
[TBL] [Abstract][Full Text] [Related]
54. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.
Cavallo LM; Solari D; Tasiou A; Esposito F; de Angelis M; D'Enza AI; Cappabianca P
World Neurosurg; 2013; 80(3-4):342-50. PubMed ID: 23046913
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study.
Yamada S; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Inoshita N; Ito J
J Neurosurg Pediatr; 2018 Jun; 21(6):549-562. PubMed ID: 29600905
[TBL] [Abstract][Full Text] [Related]
56. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma.
Sheehan JP; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(5 Suppl):408-14. PubMed ID: 12507066
[TBL] [Abstract][Full Text] [Related]
57. Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach.
Gondim JA; Almeida JP; Albuquerque LA; Gomes EF; Schops M
World Neurosurg; 2014; 82(1-2):e281-90. PubMed ID: 23994073
[TBL] [Abstract][Full Text] [Related]
58. Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.
Paľa A; Etzrodt-Walter G; Karpel-Massler G; Pedro MT; Mayer B; Coburger J; Wirtz CR; Hlaváč M
Neurosurg Rev; 2022 Apr; 45(2):1701-1708. PubMed ID: 34855027
[TBL] [Abstract][Full Text] [Related]
59. Clinical and Pathologic Characteristics Predicted the Postoperative Recurrence and Progression of Pituitary Adenoma: A Retrospective Study with 10 Years Follow-Up.
Lv L; Yin S; Zhou P; Hu Y; Chen C; Ma W; Jiang Y; Wang Z; Jiang S
World Neurosurg; 2018 Oct; 118():e428-e435. PubMed ID: 29981466
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Complications and Costs During Overlapping Transsphenoidal Surgery in the Treatment of Pituitary Adenoma.
Karsy M; Bowers CA; Scoville J; Kundu B; Azab MA; Gee JM; Guan J; Couldwell WT
Neurosurgery; 2019 May; 84(5):1104-1111. PubMed ID: 29897572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
